113 related articles for article (PubMed ID: 7611812)
1. Cutaneous chronic graft-vs-host disease and hepatitis C virus.
Bouloc A; Pawlotsky JM; Choukroun V; Norol F; Vernant JP; Revuz J; Bagot M
Arch Dermatol; 1995 Jul; 131(7):853-5. PubMed ID: 7611812
[No Abstract] [Full Text] [Related]
2. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
3. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis C virus antibodies in renal transplant patients.
Chaudhary RK; Rossier E
Can Dis Wkly Rep; 1991 Mar; 17(10):53-4. PubMed ID: 1709831
[No Abstract] [Full Text] [Related]
5. [Hepatitis C and chronic alcoholic hepatopathy].
Pagani A; Sala N; Zigliani P; Galante T
Recenti Prog Med; 1994 Sep; 85(9):429-32. PubMed ID: 7938874
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection and chronic liver disease after bone marrow transplantation--the Taiwan experience.
Chen PM; Chiou TJ; Liu JH; Fan FS; Hsieh RK; Wei CH; Liu RS; Tzeng CH
Transplant Proc; 1993 Aug; 25(4 Suppl 3):65-6. PubMed ID: 7688914
[No Abstract] [Full Text] [Related]
7. [Graft vs host disease of the skin].
Martín Ortega E
Med Clin (Barc); 1990 Feb; 94(5):180-3. PubMed ID: 2325478
[No Abstract] [Full Text] [Related]
8. Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease.
Nagler A; Goldenhersh MA; Levi-Schaffer F; Bystryn JC; Klaus SN
Br J Dermatol; 1996 Apr; 134(4):780-3. PubMed ID: 8733392
[TBL] [Abstract][Full Text] [Related]
9. [The prevalence of antibodies to the hepatitis C virus (HCV) in patients with post-transfusional hepatitis and blood donors in Moldova].
Iancu L; Turcu T; Apetrei C; Porumb S; Dimitriu S; Donţu G; Mândru R; Moraru E; Duca M
Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):76-80. PubMed ID: 9132116
[No Abstract] [Full Text] [Related]
10. Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution.
Freemer CS; Farmer ER; Corio RL; Altomonte VL; Wagner JE; Vogelsang GB; Santos GW
Arch Dermatol; 1994 Jan; 130(1):70-2. PubMed ID: 8285743
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous chronic graft-versus-host disease localized to the field of total lymphoid irradiation.
Okamoto S; Takahashi S; Inoue T; Tojo A; Tani K; Kikuchi A; Shimizu H; Nishikawa T; Ikeda Y; Asano S
Bone Marrow Transplant; 1996 Jan; 17(1):111-3. PubMed ID: 8673042
[TBL] [Abstract][Full Text] [Related]
12. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
Hirokawa M; Kume M; Wu T; Ishikawa K; Sawada KI
Bone Marrow Transplant; 2006 Sep; 38(5):387-8. PubMed ID: 16862163
[No Abstract] [Full Text] [Related]
13. Prevalence and presentation of hepatitis C related chronic liver disease in southern India.
Issar SK; Ramakrishna BS; Ramakrishna B; Christopher S; Samuel BU; John TJ
J Trop Med Hyg; 1995 Jun; 98(3):161-5. PubMed ID: 7783272
[TBL] [Abstract][Full Text] [Related]
14. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F
Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949
[No Abstract] [Full Text] [Related]
15. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
Ziemer M; Thiele JJ; Gruhn B; Elsner P
J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
[No Abstract] [Full Text] [Related]
16. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
Ka MM; Ndiaye MF; Herve P; Legueno B; Diop BM; Dangou JM; Niang A; Woto-Gaye G; Mendes V; Diop TM; Ndiaye PD; Bao O
Dakar Med; 1996; Spec No():59-62. PubMed ID: 14520992
[No Abstract] [Full Text] [Related]
18. Toxic absorption of tacrolimus [corrected] in a patient with severe acute graft-versus-host disease.
Neuman DL; Farrar JE; Moresi JM; Vogelsang GB; Higman MA
Bone Marrow Transplant; 2005 Nov; 36(10):919-20. PubMed ID: 16151424
[No Abstract] [Full Text] [Related]
19. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
Pretnar J; Cernelc P; Mlakar U; Fortuna M
Bone Marrow Transplant; 1996 Oct; 18(4):826. PubMed ID: 8899209
[No Abstract] [Full Text] [Related]
20. High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders.
Cavanna L; Sbolli G; Tanzi E; Romanò L; Civardi G; Buscarini E; Vallisa D; Berté R; Rossi A
Haematologica; 1995; 80(5):486-7. PubMed ID: 8566896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
